Keflin (cephalothin) is a small molecule pharmaceutical. Cephalothin was first approved as Keflin on 1982-01-01. It is used to treat bacterial skin diseases, escherichia coli infections, klebsiella infections, proteus infections, and respiratory tract infections amongst others in the USA. It is known to target solute carrier family 22 member 8 and solute carrier family 22 member 11.
|Indication||bacterial skin diseases, escherichia coli infections, klebsiella infections, proteus infections, respiratory tract infections, soft tissue infections, staphylococcal infections, streptococcal infections, urinary tract infections|